These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34765296)

  • 1. LncRNA NR2F2-AS1 induces epithelial-mesenchymal transition of non-small cell lung cancer by modulating BVR/ATF-2 pathway via regulating miR-545-5p/c-Met axis.
    Liu C; Li QG; Zhou Y; Cao YY; Wei ZX; Jin YH; Wang X; Chen YY; Qi L; Geng JX; Liu F
    Am J Cancer Res; 2021; 11(10):4844-4865. PubMed ID: 34765296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
    Wu C; Lin W; Fu F
    Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA TTN-AS1 Promotes Progression of Non-Small Cell Lung Cancer via Regulating miR-491-5p/ZNF503 Axis.
    Qi G; Li L
    Onco Targets Ther; 2020; 13():6361-6371. PubMed ID: 32669856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
    Cui F; Luo P; Bai Y; Meng J
    Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
    Liu T; Yang C; Wang W; Liu C
    Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA NKX2-1-AS1 Accelerates Non-Small Cell Lung Cancer Progression through the miR-589-5p/NME1 Axis.
    Chen X; Jiang R; Huang X; Chen L; Hu X; Wei Y
    Cell Biochem Biophys; 2024 Aug; ():. PubMed ID: 39117986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.
    Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM
    Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AZIN1-AS1, A Novel Oncogenic LncRNA, Promotes the Progression of Non-Small Cell Lung Cancer by Regulating MiR-513b-5p and DUSP11.
    Cai Y; Wu Q; Liu Y; Wang J
    Onco Targets Ther; 2020; 13():9667-9678. PubMed ID: 33116570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway.
    Shi J; Yang C; An J; Hao D; Liu C; Liu J; Sun J; Jiang J
    J Exp Clin Cancer Res; 2021 Apr; 40(1):148. PubMed ID: 33931086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CDKN2B-AS1 Promotes Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma via Sponging miR-424-5p.
    Shen X; Li Y; He F; Kong J
    Cancer Manag Res; 2020; 12():6807-6819. PubMed ID: 32801906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FAS-AS1 inhibits the progression of non-small cell lung cancer through regulating miR-19a-5p.
    Yang CB; Xiao SW; Cheng SM; Zhang C
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3775-3785. PubMed ID: 32329854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2.
    Huang N; Guo W; Ren K; Li W; Jiang Y; Sun J; Dai W; Zhao W
    Front Oncol; 2019; 9():1103. PubMed ID: 31696057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-Regulation of FSTL3, Regulated by lncRNA DSCAM-AS1/miR-122-5p Axis, Promotes Proliferation and Migration of Non-Small Cell Lung Cancer Cells.
    Gao L; Chen X; Wang Y; Zhang J
    Onco Targets Ther; 2020; 13():2725-2738. PubMed ID: 32280246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p.
    Fu JX; Sun GQ; Wang HL; Jiang HX
    J Biol Regul Homeost Agents; 2020; 34(3):961-968. PubMed ID: 32519534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.